` 603896 (Zhejiang Shouxiangu Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

603896
vs
S
Shanghai Composite

Over the past 12 months, Zhejiang Shouxiangu Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +3% compared to the Shanghai Composite's +28% growth.

Stocks Performance
603896 vs Shanghai Composite

Loading
603896
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603896 vs Shanghai Composite

Performance Gap Between 603896 and SSEC
HIDDEN
Show

Performance By Year
603896 vs Shanghai Composite

Loading
603896
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Zhejiang Shouxiangu Pharmaceutical Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.1B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Zhejiang Shouxiangu Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top